Global Information
회사소개 | 문의 | 비교리스트

세계의 자기주사기 시장 예측(-2027년) : 치료별, 유형별, 투여 경로별, 최종사용자별, 지역별 - COVID-19의 누적 영향

Autoinjectors Market Research Report by Therapy, Type, Route of Administration, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

리서치사 360iResearch LLP
발행일 2022년 06월 상품코드 1089742
페이지 정보 영문 195 Pages 배송안내 1-2일 (영업일 기준)
가격
US $ 3,949 ₩ 5,187,000 Online Access (Single User License - 1 Year)
US $ 4,949 ₩ 6,501,000 PDF (Single User License) + Excel
US $ 5,949 ₩ 7,814,000 PDF (1-5 User License) + Excel
US $ 7,949 ₩ 10,441,000 PDF (Site License) + Excel
US $ 9,949 ₩ 13,069,000 PDF (Enterprise User License) + Excel


세계의 자기주사기 시장 예측(-2027년) : 치료별, 유형별, 투여 경로별, 최종사용자별, 지역별 - COVID-19의 누적 영향 Autoinjectors Market Research Report by Therapy, Type, Route of Administration, End User, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19
발행일 : 2022년 06월 페이지 정보 : 영문 195 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 자기주사기 시장 규모는 12.24%의 연평균 복합 성장률(CAGR)로 확대되어 2027년까지 479억 9,000만 달러에 달할 것으로 예측됩니다.

세계의 자기주사기(Autoinjectors) 시장에 대해 조사했으며, 시장 성장 촉진요인 및 억제요인, 시장 기회, 과제, 치료별·유형별·투여 경로별·최종사용자별·지역별 시장 분석, 경쟁 구도, 기업 프로파일 등의 정보를 담았습니다.

목차

제1장 서문

  • 조사 목적
  • 시장 세분화와 범위
  • 조사 대상 기간
  • 통화와 가격
  • 언어
  • 제한사항
  • 전제조건
  • 이해관계자

제2장 조사 방법

제3장 개요

제4장 시장 개요

제5장 시장 인사이트

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제
  • COVID-19의 누적 영향

제6장 자기주사기 시장 : 치료별

  • 아나필락시스
  • 당뇨병
  • 다발성 경화증
  • 류마티스 관절염

제7장 자기주사기 시장 : 유형별

  • 일회용
  • 재이용 가능

제8장 자기주사기 시장 : 투여 경로별

  • 근육내
  • 피하

제9장 자기주사기 시장 : 최종사용자별

  • 외래 치료 환경
  • 재택 의료 환경
  • 병원 및 진료소

제10장 아메리카의 자기주사기 시장

  • 아르헨티나
  • 브라질
  • 캐나다
  • 멕시코
  • 미국

제11장 아시아태평양의 자기주사기 시장

  • 호주
  • 중국
  • 인도
  • 인도네시아
  • 일본
  • 말레이시아
  • 필리핀
  • 싱가포르
  • 한국
  • 대만
  • 태국

제12장 유럽, 중동 및 아프리카의 자기주사기 시장

  • 프랑스
  • 독일
  • 이탈리아
  • 네덜란드
  • 카타르
  • 러시아
  • 사우디아라비아
  • 남아프리카공화국
  • 스페인
  • 아랍에미리트(UAE)
  • 영국

제13장 경쟁 구도

  • FPNV 포지셔닝 매트릭스
    • 상한
    • 사업 전략
    • 제품 만족도
  • 시장 순위 분석
  • 시장 점유율 분석 : 주요 기업별
  • 경쟁 시나리오
    • 인수합병(M&A)
    • 합의/협업/파트너십
    • 신제품 출시 및 개선
    • 투자 및 펀딩
    • 수상/인정/확장

제14장 기업 개요

  • Abbvie Inc.
  • Amgen Inc.
  • Antares Pharma
  • AstraZeneca plc
  • Becton, Dickinson And Company
  • Biogen, Inc.
  • Consort Medical
  • Eli Lilly And Company
  • GlaxoSmithKline PLC
  • Haselmeier
  • Johnson & Johnson Services Inc.
  • Kaleo, Inc.
  • Merck Group
  • Mylan N.V.
  • Novartis AG
  • Owen Mumford Ltd
  • Sanofi S.A.
  • Shl Medical AG
  • Teva Pharmaceutical Industries Ltd
  • Ypsomed AG

제15장 부록

  • 디스커션 가이드
  • 라이선스와 가격
LSH 22.06.23

LIST OF FIGURES

  • FIGURE 1. GLOBAL AUTOINJECTORS MARKET: DYNAMICS
  • FIGURE 2. GLOBAL AUTOINJECTORS MARKET SIZE, BY THERAPY, 2021 VS 2027 (%)
  • FIGURE 3. GLOBAL AUTOINJECTORS MARKET SIZE, BY THERAPY, 2021 VS 2027 (USD BILLION)
  • FIGURE 4. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOINJECTORS MARKET SIZE, BY THERAPY, 2027
  • FIGURE 5. GLOBAL AUTOINJECTORS MARKET SIZE, BY ANAPHYLAXIS, 2019-2027 (USD BILLION)
  • FIGURE 6. GLOBAL AUTOINJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 7. GLOBAL AUTOINJECTORS MARKET SIZE, BY DIABETES, 2019-2027 (USD BILLION)
  • FIGURE 8. GLOBAL AUTOINJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 9. GLOBAL AUTOINJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, 2019-2027 (USD BILLION)
  • FIGURE 10. GLOBAL AUTOINJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 11. GLOBAL AUTOINJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, 2019-2027 (USD BILLION)
  • FIGURE 12. GLOBAL AUTOINJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 13. GLOBAL AUTOINJECTORS MARKET SIZE, BY TYPE, 2021 VS 2027 (%)
  • FIGURE 14. GLOBAL AUTOINJECTORS MARKET SIZE, BY TYPE, 2021 VS 2027 (USD BILLION)
  • FIGURE 15. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOINJECTORS MARKET SIZE, BY TYPE, 2027
  • FIGURE 16. GLOBAL AUTOINJECTORS MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, 2019-2027 (USD BILLION)
  • FIGURE 17. GLOBAL AUTOINJECTORS MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 18. GLOBAL AUTOINJECTORS MARKET SIZE, BY REUSABLE AUTOINJECTORS, 2019-2027 (USD BILLION)
  • FIGURE 19. GLOBAL AUTOINJECTORS MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 20. GLOBAL AUTOINJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (%)
  • FIGURE 21. GLOBAL AUTOINJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2021 VS 2027 (USD BILLION)
  • FIGURE 22. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOINJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2027
  • FIGURE 23. GLOBAL AUTOINJECTORS MARKET SIZE, BY INTRAMUSCULAR, 2019-2027 (USD BILLION)
  • FIGURE 24. GLOBAL AUTOINJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 25. GLOBAL AUTOINJECTORS MARKET SIZE, BY SUBCUTANEOUS, 2019-2027 (USD BILLION)
  • FIGURE 26. GLOBAL AUTOINJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 27. GLOBAL AUTOINJECTORS MARKET SIZE, BY END USER, 2021 VS 2027 (%)
  • FIGURE 28. GLOBAL AUTOINJECTORS MARKET SIZE, BY END USER, 2021 VS 2027 (USD BILLION)
  • FIGURE 29. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL AUTOINJECTORS MARKET SIZE, BY END USER, 2027
  • FIGURE 30. GLOBAL AUTOINJECTORS MARKET SIZE, BY AMBULATORY CARE SETTINGS, 2019-2027 (USD BILLION)
  • FIGURE 31. GLOBAL AUTOINJECTORS MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 32. GLOBAL AUTOINJECTORS MARKET SIZE, BY HOME CARE SETTINGS, 2019-2027 (USD BILLION)
  • FIGURE 33. GLOBAL AUTOINJECTORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 34. GLOBAL AUTOINJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, 2019-2027 (USD BILLION)
  • FIGURE 35. GLOBAL AUTOINJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2021 VS 2027 (USD BILLION)
  • FIGURE 36. AMERICAS AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 37. ARGENTINA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 38. BRAZIL AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 39. CANADA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 40. MEXICO AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 41. UNITED STATES AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 42. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 43. AUSTRALIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 44. CHINA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 45. INDIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 46. INDONESIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 47. JAPAN AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 48. MALAYSIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 49. PHILIPPINES AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 50. SINGAPORE AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 51. SOUTH KOREA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 52. TAIWAN AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 53. THAILAND AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 54. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 55. FRANCE AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 56. GERMANY AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 57. ITALY AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 58. NETHERLANDS AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 59. QATAR AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 60. RUSSIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 61. SAUDI ARABIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 62. SOUTH AFRICA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 63. SPAIN AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 64. UNITED ARAB EMIRATES AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 65. UNITED KINGDOM AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • FIGURE 66. GLOBAL AUTOINJECTORS MARKET: FPNV POSITIONING MATRIX
  • FIGURE 67. GLOBAL AUTOINJECTORS MARKET: SHARE, BY KEY PLAYER, 2021
  • FIGURE 68. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL AUTOINJECTORS MARKET, BY TYPE

LIST OF TABLES

  • TABLE 1. GLOBAL AUTOINJECTORS MARKET: SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2016-2020
  • TABLE 3. GLOBAL AUTOINJECTORS MARKET SIZE, BY THERAPY, 2019-2027 (USD BILLION)
  • TABLE 4. GLOBAL AUTOINJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 5. AMERICAS AUTOINJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 6. UNITED STATES AUTOINJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 7. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 8. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 9. GLOBAL AUTOINJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 10. AMERICAS AUTOINJECTORS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 11. UNITED STATES AUTOINJECTORS MARKET SIZE, BY DIABETES, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 12. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 13. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY DIABETES, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 14. GLOBAL AUTOINJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 15. AMERICAS AUTOINJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 16. UNITED STATES AUTOINJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 17. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 18. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 19. GLOBAL AUTOINJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 20. AMERICAS AUTOINJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 21. UNITED STATES AUTOINJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 22. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 23. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 24. GLOBAL AUTOINJECTORS MARKET SIZE, BY TYPE, 2019-2027 (USD BILLION)
  • TABLE 25. GLOBAL AUTOINJECTORS MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 26. AMERICAS AUTOINJECTORS MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 27. UNITED STATES AUTOINJECTORS MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 28. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 29. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY DISPOSABLE AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 30. GLOBAL AUTOINJECTORS MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 31. AMERICAS AUTOINJECTORS MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 32. UNITED STATES AUTOINJECTORS MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 33. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 34. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY REUSABLE AUTOINJECTORS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 35. GLOBAL AUTOINJECTORS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2019-2027 (USD BILLION)
  • TABLE 36. GLOBAL AUTOINJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 37. AMERICAS AUTOINJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 38. UNITED STATES AUTOINJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 39. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 40. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY INTRAMUSCULAR, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 41. GLOBAL AUTOINJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 42. AMERICAS AUTOINJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 43. UNITED STATES AUTOINJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 44. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 45. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY SUBCUTANEOUS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 46. GLOBAL AUTOINJECTORS MARKET SIZE, BY END USER, 2019-2027 (USD BILLION)
  • TABLE 47. GLOBAL AUTOINJECTORS MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 48. AMERICAS AUTOINJECTORS MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 49. UNITED STATES AUTOINJECTORS MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 50. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 51. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY AMBULATORY CARE SETTINGS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 52. GLOBAL AUTOINJECTORS MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 53. AMERICAS AUTOINJECTORS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 54. UNITED STATES AUTOINJECTORS MARKET SIZE, BY HOME CARE SETTINGS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 55. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY HOME CARE SETTINGS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 57. GLOBAL AUTOINJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2019-2027 (USD BILLION)
  • TABLE 58. AMERICAS AUTOINJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 59. UNITED STATES AUTOINJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY STATE, 2019-2027 (USD BILLION)
  • TABLE 60. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2019-2027 (USD BILLION)
  • TABLE 62. AMERICAS AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 63. ARGENTINA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 64. BRAZIL AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 65. CANADA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 66. MEXICO AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 67. UNITED STATES AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 68. ASIA-PACIFIC AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 69. AUSTRALIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 70. CHINA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 71. INDIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 72. INDONESIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 73. JAPAN AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 74. MALAYSIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 75. PHILIPPINES AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 76. SINGAPORE AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 77. SOUTH KOREA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 78. TAIWAN AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 79. THAILAND AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 81. FRANCE AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 82. GERMANY AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 83. ITALY AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 84. NETHERLANDS AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 85. QATAR AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 86. RUSSIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 87. SAUDI ARABIA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 88. SOUTH AFRICA AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 89. SPAIN AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 90. UNITED ARAB EMIRATES AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 91. UNITED KINGDOM AUTOINJECTORS MARKET SIZE, 2019-2027 (USD BILLION)
  • TABLE 92. GLOBAL AUTOINJECTORS MARKET: SCORES
  • TABLE 93. GLOBAL AUTOINJECTORS MARKET: BUSINESS STRATEGY
  • TABLE 94. GLOBAL AUTOINJECTORS MARKET: PRODUCT SATISFACTION
  • TABLE 95. GLOBAL AUTOINJECTORS MARKET: RANKING
  • TABLE 96. GLOBAL AUTOINJECTORS MARKET: SHARE, BY KEY PLAYER, 2021
  • TABLE 97. GLOBAL AUTOINJECTORS MARKET: MERGER & ACQUISITION
  • TABLE 98. GLOBAL AUTOINJECTORS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  • TABLE 99. GLOBAL AUTOINJECTORS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  • TABLE 100. GLOBAL AUTOINJECTORS MARKET: INVESTMENT & FUNDING
  • TABLE 101. GLOBAL AUTOINJECTORS MARKET: AWARD, RECOGNITION, & EXPANSION
  • TABLE 102. GLOBAL AUTOINJECTORS MARKET: LICENSE & PRICING

The Global Autoinjectors Market grew USD 47.99 billion by 2027, at a CAGR of 12.24%.

The Global Autoinjectors Market size was estimated at USD 23.99 billion in 2021 and expected to reach USD 26.87 billion in 2022, and is projected to grow at a CAGR 12.24% to reach USD 47.99 billion by 2027.

Market Statistics:

The report provides market sizing and forecast across five major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2019 and 2020 are considered historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered the forecast period.

Market Segmentation & Coverage:

This research report categorizes the Autoinjectors to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Therapy, the market was studied across Anaphylaxis, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.

Based on Type, the market was studied across Disposable Autoinjectors and Reusable Autoinjectors.

Based on Route of Administration, the market was studied across Intramuscular and Subcutaneous.

Based on End User, the market was studied across Ambulatory Care Settings, Home Care Settings, and Hospitals & Clinics.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, and Thailand. The Europe, Middle East & Africa is further studied across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:

We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Autoinjectors market considering the current update on the conflict and its global response.

Competitive Strategic Window:

The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Autoinjectors Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:

The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor's strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Autoinjectors Market, including Abbvie Inc., Amgen Inc., Antares Pharma, AstraZeneca plc, Becton, Dickinson And Company, Biogen, Inc., Consort Medical, Eli Lilly And Company, GlaxoSmithKline PLC, Haselmeier, Johnson & Johnson Services Inc., Kaleo, Inc., Merck Group, Mylan N.V., Novartis AG, Owen Mumford Ltd, Sanofi S.A., Shl Medical AG, Teva Pharmaceutical Industries Ltd, and Ypsomed AG.

The report provides insights on the following pointers:

  • 1. Market Penetration: Provides comprehensive information on the market offered by the key players
  • 2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
  • 3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
  • 4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
  • 5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

  • 1. What is the market size and forecast of the Global Autoinjectors Market?
  • 2. What are the inhibiting factors and impact of COVID-19 shaping the Global Autoinjectors Market during the forecast period?
  • 3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Autoinjectors Market?
  • 4. What is the competitive strategic window for opportunities in the Global Autoinjectors Market?
  • 5. What are the technology trends and regulatory frameworks in the Global Autoinjectors Market?
  • 6. What is the market share of the leading vendors in the Global Autoinjectors Market?
  • 7. What modes and strategic moves are considered suitable for entering the Global Autoinjectors Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of targeted thera and rising incidence of anaphylaxis
      • 5.1.1.2. Reimbursement and government support for autoinjectors
      • 5.1.1.3. Rising number of regulatory approvals of new autoinjectors
    • 5.1.2. Restraints
      • 5.1.2.1. Alternative drug delivery mode
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing need for limiting patient visits and physical contact
      • 5.1.3.2. Technological advancements in device function and growing preference for painless injection techniques
    • 5.1.4. Challenges
      • 5.1.4.1. Development of autoinjectors for multiple drug viscosities
  • 5.2. Cumulative Impact of COVID-19

6. Autoinjectors Market, by Therapy

  • 6.1. Introduction
  • 6.2. Anaphylaxis
  • 6.3. Diabetes
  • 6.4. Multiple Sclerosis
  • 6.5. Rheumatoid Arthritis

7. Autoinjectors Market, by Type

  • 7.1. Introduction
  • 7.2. Disposable Autoinjectors
  • 7.3. Reusable Autoinjectors

8. Autoinjectors Market, by Route of Administration

  • 8.1. Introduction
  • 8.2. Intramuscular
  • 8.3. Subcutaneous

9. Autoinjectors Market, by End User

  • 9.1. Introduction
  • 9.2. Ambulatory Care Settings
  • 9.3. Home Care Settings
  • 9.4. Hospitals & Clinics

10. Americas Autoinjectors Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Autoinjectors Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand

12. Europe, Middle East & Africa Autoinjectors Market

  • 12.1. Introduction
  • 12.2. France
  • 12.3. Germany
  • 12.4. Italy
  • 12.5. Netherlands
  • 12.6. Qatar
  • 12.7. Russia
  • 12.8. Saudi Arabia
  • 12.9. South Africa
  • 12.10. Spain
  • 12.11. United Arab Emirates
  • 12.12. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
    • 13.1.1. Quadrants
    • 13.1.2. Business Strategy
    • 13.1.3. Product Satisfaction
  • 13.2. Market Ranking Analysis
  • 13.3. Market Share Analysis, By Key Player
  • 13.4. Competitive Scenario
    • 13.4.1. Merger & Acquisition
    • 13.4.2. Agreement, Collaboration, & Partnership
    • 13.4.3. New Product Launch & Enhancement
    • 13.4.4. Investment & Funding
    • 13.4.5. Award, Recognition, & Expansion

14. Company Usability Profiles

  • 14.1. Abbvie Inc.
  • 14.2. Amgen Inc.
  • 14.3. Antares Pharma
  • 14.4. AstraZeneca plc
  • 14.5. Becton, Dickinson And Company
  • 14.6. Biogen, Inc.
  • 14.7. Consort Medical
  • 14.8. Eli Lilly And Company
  • 14.9. GlaxoSmithKline PLC
  • 14.10. Haselmeier
  • 14.11. Johnson & Johnson Services Inc.
  • 14.12. Kaleo, Inc.
  • 14.13. Merck Group
  • 14.14. Mylan N.V.
  • 14.15. Novartis AG
  • 14.16. Owen Mumford Ltd
  • 14.17. Sanofi S.A.
  • 14.18. Shl Medical AG
  • 14.19. Teva Pharmaceutical Industries Ltd
  • 14.20. Ypsomed AG

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing
Back to Top
전화 문의
F A Q